Professional background

Pedro Machado FRCP PhD, is a Professor & Consultant in Rheumatology and Neuromuscular Diseases at University College London (UCL), University College London Hospitals (UCLH), and Northwick Park Hospital. He is a principal investigator at the UCL Department of Neuromuscular Diseases (Institute of Neurology) and the UCL Centre for Rheumatology (Division of Medicine). Dr Machado runs both specialist spondyloarthritis (rheumatology department) and myopathy/myositis (neuromuscular department) clinics. He also leads the needle muscle biopsy service at UCLH, which he implemented at the Trust in 2023.

His research interests include the investigation of new therapeutic strategies and the assessment and prediction of outcomes in rheumatic diseases, with a focus on muscle diseases and axial spondyloarthritis. He also has an interest in COVID-19, particularly in the outcome of COVID-19 in patients with rheumatic and neuromuscular diseases. 

He has published over 250 articles and seven book chapters. He has been awarded four fellowships and 14 scientific prizes, including the prestigious Michael Mason Award presented by the British Society for Rheumatology (BSR) to recognise excellence in clinical and scientific research. 

He is the past-chair of the European Alliance of Associations for Rheumatology (EULAR) Standing Committee on Epidemiology and Health Services Research (SCEHSR), Vice-Chair of the Myositis International Health and Research Collaborative Alliance (MIHRA), and a member of the Assessment of Spondyloarthritis International Society (ASAS) Executive Committee, the British Society of Spondyloarthritis (BRITSpA) Executive Committee, the COVID-19 Global Rheumatology Alliance Steering Committee, the EULAR-COVID-19 Registry steering group, the British Society of Rheumatology (BSR), The American College of Rheumatology (ACR), The Portuguese Society of Rheumatology (SPR), The International Myositis Assessment & Clinical Studies Group (IMACS), The Muscle Study Group (MSG), and The British Myology Society (BMS). He is also past-chair (2013–2014) of the Emerging EULAR Network (EMEUNET). 

Research interests

  • Spondyloarthritis
  • Myositis/neuromuscular diseases
  • Musculoskeletal Imaging
  • Clinical trials
  • Epidemiology
  • COVID-19